Target intelligence / Profile preview

Urogenital tract pathogenic microorganisms

Molecular classification
Other
01

Overview

Urogenital tract pathogenic microorganisms encompass a broad spectrum of infectious agents, including bacteria, viruses, fungi, and protozoa, that affect the urinary and reproductive tracts. Common bacterial uropathogens like Escherichia coli are the primary cause of urinary tract infections (UTIs), while organisms such as Neisseria gonorrhoeae and Chlamydia trachomatis are responsible for sexually transmitted infections (STIs) (StatPearls: Urinary Tract Infection, 2023). These pathogens utilize specialized virulence factors to adhere to mucosal surfaces, invade host tissues, and evade immune responses (NIH: Sexually Transmitted Diseases, 2022). Therapeutic intervention relies on a variety of antimicrobial classes that target specific microbial structures or enzymes, such as the bacterial ribosome or DNA gyrase. The clinical management of these pathogens is increasingly complicated by the global emergence of antimicrobial resistance, necessitating the development of new therapeutic strategies and diagnostic tools (CDC: Antibiotic Resistance Threats, 2019).

Other names
Genitourinary pathogensUropathogensSexually transmitted pathogensUrogenital tract infections (pathogens)
02

Mechanism of action

Drugs targeting these microorganisms typically act by inhibiting essential microbial processes, including cell wall synthesis (beta-lactams), protein synthesis (macrolides), DNA replication (fluoroquinolones), or metabolic pathways (sulfonamides).

03

Biological functions

InfectionPathogenesisColonizationBiofilm formationImmune evasion
04

Disease associations

Urinary tract infectionSexually transmitted infectionCystitisPyelonephritisProstatitisVaginitis
05

Safety considerations

Antimicrobial resistanceDisruption of normal flora (dysbiosis)Hypersensitivity reactionsOrgan toxicity (e.g., nephrotoxicity)
06

Interacting drugs

Ciprofloxacin

6 more in the full profile.

07

Biomarkers

Leukocyte esteraseNitritesMicrobial cultureNucleic acid amplification test (NAAT)C-reactive protein

Beyond the preview

Go deeper on Urogenital tract pathogenic microorganisms.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urogenital tract pathogenic microorganisms.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call